Roivant Sciences (ROIV) Non Operating Investment Income (2020 - 2025)

Roivant Sciences' Non Operating Investment Income history runs 6 years deep, the most recent figure standing at $131.0 million for Q4 2025.

• Quarterly Non Operating Investment Income rose 209.71% year-over-year to $131.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $282.6 million (up 572.8% YoY) and the FY2026 annual result came in at $105.0 million, up 90.35% from the prior year.
• Non Operating Investment Income was $131.0 million for Q4 2025 at Roivant Sciences, up from $128.5 million in the prior quarter.
• Across five years, Non Operating Investment Income topped out at $443.8 million in Q3 2021 and bottomed at -$63.9 million in Q4 2023.
• A 5-year average of $65.0 million and a median of -$7.6 million in 2023 frame the typical range for Non Operating Investment Income.
• Annual changes were most pronounced in 2021 — Non Operating Investment Income surged 426.42% — and 2025, when it sank 225.61%.
• Roivant Sciences' Non Operating Investment Income stood at $443.8 million in 2021, then plunged by 112.01% to -$53.3 million in 2022, then fell by 19.9% to -$63.9 million in 2023, then surged by 166.2% to $42.3 million in 2024, then jumped by 209.71% to $131.0 million in 2025.
• Business Quant data shows ROIV's Non Operating Investment Income at $131.0 million in Q4 2025, $128.5 million in Q3 2025, and -$19.1 million in Q2 2025.